DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neuromodulation to Facilitate the Effect of Ketamine

Information source: The Neuroscience Center, LLC
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Depression; Chronic Pain; Substance Abuse

Intervention: co-administration of TMS and infused ketamine (Other)

Phase: N/A

Status: Completed

Sponsored by: The Neuroscience Center, LLC

Official(s) and/or principal investigator(s):
Steven R Devore Best, M.D., Principal Investigator, Affiliation: The Neuroscience Center


application of external neuromodulation along with ketamine infusion.

Clinical Details

Official title: Treatment of Thalamocortical Dysrhythmia Using External Neuromodulation to Facilitate the Therapeutic Effect of Ketamine.

Study design: Observational Model: Case Control, Time Perspective: Retrospective

Primary outcome: Global Assessment of Function in DSM-4R

Detailed description: apply TMS concurrent with ketamine infusion in order to increase the likliehood & strength of therapeutic benefit


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- chronically ill,

- treatment-resistant

Exclusion Criteria:

- active psychosis

Locations and Contacts

The Neuroscience Center, Deerfield, Illinois 60015, United States
Additional Information

Starting date: January 2011
Last updated: March 20, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017